Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 32Pain, Postoperative 5Depression 3Anxiety Disorders 3Neoplasm Metastasis 2Fatigue 2Triple Negative Breast Neoplasms 1Sleep Initiation and Maintenance Disorders 1Skin Abnormalities 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Mastodynia 1Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia 1Chronic Pain 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasm Malignant Primary 1Breast Cancer Female 1Agnosia 1

Interventions

Cognitive Training 2Vitamin D 1Tobacco Use Cessation Devices 1Synbiotics 1Sodium Chloride 1Saline Solution 1Prebiotics 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-Related Cognitive Impairment × Saline Solution × Breast × Clear all
NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Sun Yat-sen University

Phase 3 Terminated
76 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡